Track topics on Twitter Track topics that are important to you
BASEL (dpa-AFX) - Novartis AG (NVS) said that it would exit antibacterial and antiviral research, the latest in a string of big-pharma departures from the field and the latest move in the company'...
Original Article: Novartis To Exit Antibiotic And Antiviral ResearchNEXT ARTICLE
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...